Cargando…
C(3)N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease
Despite the accumulating evidence linking the development of Alzheimer’s disease (AD) to the aggregation of Aβ peptides and the emergence of Aβ oligomers, the FDA has approved very few anti-aggregation-based therapies over the past several decades. Here, we report the discovery of an Aβ peptide aggr...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504243/ https://www.ncbi.nlm.nih.gov/pubmed/37714837 http://dx.doi.org/10.1038/s41467-023-41489-y |